Overview
Matwings provides computational chemistry and AI-driven novel drug molecule design.
Funding
Amounts as reported; USD estimates shown only when they matchListed 5 funding records. Latest funding: RMB 200M (Series A+), Feb 6, 2026.
3 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Jul 13, 2026 | Hundreds of millions of RMB · Series A+ | Qiming Venture Capital, 上海未来涌现企业咨询合伙企业（有限合伙）, 上海涵泽创业投资合伙企业（有限合伙）, 上海科创基金, 嘉兴润璞天鹜股权投资合伙企业（有限合伙）, 国投创新, 本草资本, 涌铧, 聚杰微纤, 财鑫资本, 金景资本 | No source link |
Evidence Matwings raises hundreds of millions of RMB in Series A+ financingOn 2026-07-13, according to Xiniu Data, Matwings completed Series A+ financing, raising hundreds of millions of RMB. Investors were co-lead investor Shanghai Weilaiyongxianqiye Consulting Partnership (Limited Partnership), co-lead investor Guotou Innovation, participating investor Jujieweixian, participating investor Jiaxingrunputianwuguquan Investment Partnership (Limited Partnership), participating investor Jinjing Capital, participating investor Shanghai Hanze Venture Capital Partnership (Limited Partnership), participating investor Caixin Capital, participating investor Qiming Venture Capital, participating investor Yonghua Investment, participating investor Bencao Capital, participating investor Shanghai Kechuang Fund. The company is a provider of AI-driven full-stack protein research and development platforms. Translated source brief, not a quotation. Check the original before citing. Sources · 0
Qiming Venture Capital, 上海未来涌现企业咨询合伙企业（有限合伙）, 上海涵泽创业投资合伙企业（有限合伙）, 上海科创基金, 嘉兴润璞天鹜股权投资合伙企业（有限合伙）, 国投创新, 本草资本, 涌铧, 聚杰微纤, 财鑫资本, 金景资本 | |||
| Feb 6, 2026 | RMB 200M ≈ $28.6M · Series A+ | Qiming Venture Capital, 上海国投, 中石油昆仑资本, 国投招商, 孚腾资本, 新供销基金, 本草资本, 法默凯, 涌铧投资, 金沙江联合资本 | No source link |
Evidence Matwings raises RMB 200 million in Series A+ financingOn 2026-02-06, according to Xiniu Data, Matwings completed Series A+ financing, raising RMB 200 million. Investors were Xingongxiao Fund, Zhongshiyoukunlun Capital, Qiming Venture Capital, Futeng Capital and others. Translated source brief, not a quotation. Check the original before citing. | |||
| Jan 23, 2025 | Undisclosed · Strategic | 上海科创基金, 长春高新 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
| Nov 15, 2024 | RMB 100M ≈ $14.3M · Series A | Qiming Venture Capital, 共青城行远创业投资, 本草资本, 涌铧投资, 经韬创投 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
| Mar 10, 2022 | Tens of millions of RMB · Seed | 上海思宏投资合伙企业（有限合伙）, 商汤科技, 小苗朗程, 耀途资本 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 5 valuation records.
No chartable valuation estimates yet.
5 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Jul 13, 2026 | — · Series A+ | Qiming Venture Capital, 上海未来涌现企业咨询合伙企业（有限合伙）, 上海涵泽创业投资合伙企业（有限合伙）, 上海科创基金, 嘉兴润璞天鹜股权投资合伙企业（有限合伙）, 国投创新, 本草资本, 涌铧, 聚杰微纤, 财鑫资本, 金景资本 | No source link |
Evidence Matwings raises hundreds of millions of RMB in Series A+ financingOn 2026-07-13, according to Xiniu Data, Matwings completed Series A+ financing, raising hundreds of millions of RMB. Investors were co-lead investor Shanghai Weilaiyongxianqiye Consulting Partnership (Limited Partnership), co-lead investor Guotou Innovation, participating investor Jujieweixian, participating investor Jiaxingrunputianwuguquan Investment Partnership (Limited Partnership), participating investor Jinjing Capital, participating investor Shanghai Hanze Venture Capital Partnership (Limited Partnership), participating investor Caixin Capital, participating investor Qiming Venture Capital, participating investor Yonghua Investment, participating investor Bencao Capital, participating investor Shanghai Kechuang Fund. The company is a provider of AI-driven full-stack protein research and development platforms. Translated source brief, not a quotation. Check the original before citing. Sources · 0
Qiming Venture Capital, 上海未来涌现企业咨询合伙企业（有限合伙）, 上海涵泽创业投资合伙企业（有限合伙）, 上海科创基金, 嘉兴润璞天鹜股权投资合伙企业（有限合伙）, 国投创新, 本草资本, 涌铧, 聚杰微纤, 财鑫资本, 金景资本 | |||
| Feb 6, 2026 | — · Series A+ | Qiming Venture Capital, 上海国投, 中石油昆仑资本, 国投招商, 孚腾资本, 新供销基金, 本草资本, 法默凯, 涌铧投资, 金沙江联合资本 | No source link |
Evidence Matwings raises RMB 200 million in Series A+ financingOn 2026-02-06, according to Xiniu Data, Matwings completed Series A+ financing, raising RMB 200 million. Investors were Xingongxiao Fund, Zhongshiyoukunlun Capital, Qiming Venture Capital, Futeng Capital and others. Translated source brief, not a quotation. Check the original before citing. | |||
| Jan 23, 2025 | — · Strategic | 上海科创基金, 长春高新 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
| Nov 15, 2024 | — · Series A | Qiming Venture Capital, 共青城行远创业投资, 本草资本, 涌铧投资, 经韬创投 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
| Mar 10, 2022 | — · Seed | 上海思宏投资合伙企业（有限合伙）, 商汤科技, 小苗朗程, 耀途资本 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Explore
More Industry apps companies
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
计算化学及AI驱动创新药分子设计提供商 天鹜科技是一家计算化学及AI驱动创新药分子设计提供商